Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Florida
mi
from
Port Charlotte, FL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Florida
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Idaho
mi
from
Boise, ID
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Idaho
mi
from
Boise, ID
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Illinois
mi
from
Chicago, IL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Illinois
mi
from
Chicago, IL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Kansas
mi
from
Manhattan, KA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Kansas
mi
from
Manhattan, KA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Kentucky
mi
from
Lexington, KY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Maryland
mi
from
Baltimore, MD
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Maryland
mi
from
Baltimore, MD
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Michigan
mi
from
Detroit, MI
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Nevada
mi
from
Reno, NV
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Nevada
mi
from
Reno, NV
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New Hampshire
mi
from
Lebanon, NH
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New Hampshire
mi
from
Lebanon, NH
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New Jersey
mi
from
Hackensack, NJ
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New Jersey
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New York
mi
from
Bronx, NY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New York
mi
from
Bronx, NY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New York
mi
from
New York, NY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New York
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New York
mi
from
Stony Brook, NY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New York
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, North Carolina
mi
from
Durham, NC
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, North Carolina
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Ohio
mi
from
Columbus, OH
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Ohio
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Oklahoma
mi
from
Oklahoma City, OK
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Oregon
mi
from
Portland, OR
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Oregon
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Pennsylvania
mi
from
Philadelphia, PA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Tennessee
mi
from
Nashville, TN
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Tennessee
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
Dallas, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
Dallas, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
Fort Worth, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
San Antonio, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
San Antonio, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Virginia
mi
from
Norfolk, VA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Virginia
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Wisconsin
mi
from
Madison, WI
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, California
mi
from
Orange, CA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, California
mi
from
Orange, CA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, North Carolina
mi
from
Winston-Salem, NC
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, North Carolina
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Tennessee
mi
from
Memphis, TN
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Tennessee
mi
from
Memphis, TN
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
Greenville, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
Greenville, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
Australia, New South Wales
mi
from
Randwick,
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
Australia, New South Wales
mi
from
Randwick,
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Arizona
mi
from
Tucson, AZ
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Florida
mi
from
Loxahatchee Groves, FL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Florida
mi
from
Loxahatchee Groves, FL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Minnesota
mi
from
Saint Paul, MN
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Minnesota
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Missouri
mi
from
Saint Louis, MO
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Missouri
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
Phase 1 Safety Study of Autologous Bone Marrow-derived Mesenchymal Stem Cell-derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo, Administered Intrathecally in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  3/15/2018
Tisch MS Research Center of New York
mi
from
New York, NY
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
Phase 1 Safety Study of Autologous Bone Marrow-derived Mesenchymal Stem Cell-derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo, Administered Intrathecally in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 3/15/2018
Tisch MS Research Center of New York
mi
from
New York, NY
Click here to add this to my saved trials
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy
An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Status: Enrolling
Updated:  3/16/2018
UCLA Medical Center
mi
from
Los Angeles, CA
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy
An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Status: Enrolling
Updated: 3/16/2018
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy
An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Status: Enrolling
Updated:  3/16/2018
NYU Medical Center
mi
from
New York, NY
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy
An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Status: Enrolling
Updated: 3/16/2018
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy
An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Status: Enrolling
Updated:  3/16/2018
Hadassah University Hospital
mi
from
Jerusalem,
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy
An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Status: Enrolling
Updated: 3/16/2018
Hadassah University Hospital
mi
from
Jerusalem,
Click here to add this to my saved trials
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy
An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Status: Enrolling
Updated:  3/16/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy
An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Status: Enrolling
Updated: 3/16/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica)
Phase Ib Randomized, Double-Blind, Latin Square Crossover, Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 v. Lidocaine v. Placebo in Lumbar Radiculopathy
Status: Enrolling
Updated:  3/16/2018
Translational Pain Research, Brigham and Women's Hospital
mi
from
Boston, MA
Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica)
Phase Ib Randomized, Double-Blind, Latin Square Crossover, Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 v. Lidocaine v. Placebo in Lumbar Radiculopathy
Status: Enrolling
Updated: 3/16/2018
Translational Pain Research, Brigham and Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of the Relationship of Gut Microbial Composition and Stroke Outcome
A Study of the Relationship of Gut Microbial Composition and Stroke Outcome
Status: Enrolling
Updated:  3/16/2018
University of Virginia Health System
mi
from
Charlottesville, VA
A Study of the Relationship of Gut Microbial Composition and Stroke Outcome
A Study of the Relationship of Gut Microbial Composition and Stroke Outcome
Status: Enrolling
Updated: 3/16/2018
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
A Phase I Dose Escalation Study of Intratumoral or Intravenous Herpes Simplex Virus-1 Mutant HSV1716 in Patients With Refractory Non-Central Nervous System (Non-CNS) Solid Tumors
Status: Enrolling
Updated:  3/19/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
A Phase I Dose Escalation Study of Intratumoral or Intravenous Herpes Simplex Virus-1 Mutant HSV1716 in Patients With Refractory Non-Central Nervous System (Non-CNS) Solid Tumors
Status: Enrolling
Updated: 3/19/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Home-delivered Intervention for Depressed, Cognitively Impaired Elders
Home-delivered Intervention for Depressed, Cognitively Impaired Elders
Status: Enrolling
Updated:  3/19/2018
Weill Cornell Medical College
mi
from
White Plains, NY
Home-delivered Intervention for Depressed, Cognitively Impaired Elders
Home-delivered Intervention for Depressed, Cognitively Impaired Elders
Status: Enrolling
Updated: 3/19/2018
Weill Cornell Medical College
mi
from
White Plains, NY
Click here to add this to my saved trials
Home-delivered Intervention for Depressed, Cognitively Impaired Elders
Home-delivered Intervention for Depressed, Cognitively Impaired Elders
Status: Enrolling
Updated:  3/19/2018
Weill-Cornell Medical College
mi
from
New York, NY
Home-delivered Intervention for Depressed, Cognitively Impaired Elders
Home-delivered Intervention for Depressed, Cognitively Impaired Elders
Status: Enrolling
Updated: 3/19/2018
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability
Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents (An Open Pilot Study in Autism Spectrum Disorder)
Status: Enrolling
Updated:  3/19/2018
Yale Child Study Center
mi
from
New Haven, CT
Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability
Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents (An Open Pilot Study in Autism Spectrum Disorder)
Status: Enrolling
Updated: 3/19/2018
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Perfusion Enhancement With Respiratory Impedance in Stroke (PERI-Stroke)
Perfusion Enhancement With Respiratory Impedance in Stroke (PERI-Stroke)
Status: Enrolling
Updated:  3/19/2018
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Perfusion Enhancement With Respiratory Impedance in Stroke (PERI-Stroke)
Perfusion Enhancement With Respiratory Impedance in Stroke (PERI-Stroke)
Status: Enrolling
Updated: 3/19/2018
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rural Veterans With Post-traumatic Stress Disorder (PTSD) And Comorbid Mild Traumatic Brain Injury (TBI): A Feasibility Study
Remote Administration Of Cognitive Training Tasks In Rural Veterans With PTSD And Comorbid Mild TBI: A Feasibility Study
Status: Enrolling
Updated:  3/20/2018
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Rural Veterans With Post-traumatic Stress Disorder (PTSD) And Comorbid Mild Traumatic Brain Injury (TBI): A Feasibility Study
Remote Administration Of Cognitive Training Tasks In Rural Veterans With PTSD And Comorbid Mild TBI: A Feasibility Study
Status: Enrolling
Updated: 3/20/2018
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials